Bio Protocol vs Lumia — how do they compare? Bio Protocol trades at Rp516.18 (market cap Rp1,15T, Rp260,42M 24h volume), while Lumia trades at Rp1,375 (market cap Rp240,71M, Rp317,7M 24h volume). The key difference: Bio Protocol is far larger — about 4777.5× Lumia's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 173,7M / 238,9M LUMIA (73%) for Lumia. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Lumia for 31 Days on average.
| BIO | LUMIA | |
|---|---|---|
Market Cap | Rp1,15T | Rp240,71M |
Volume (24h) | Rp260,42M | Rp317,7M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 173,7M / 238,9M LUMIA (73%) |
Typical Hold Time | 16 Days | 31 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
Lumia is trading at Rp1,406.95 with a market cap of Rp240.04 million, showing bullish technical signals across multiple indicators. The asset maintains 73% circulation of its 238.9 million max supply, with an average hold time of 31 days. Current price sits below key support levels (S3 at Rp2,007), indicating potential downside pressure despite the overall bullish technical picture.
Overall outlook remains cautiously optimistic given strong technical momentum, though investors should monitor the price's position relative to support levels. Key opportunities include potential rebound from oversold conditions, while major risks involve low liquidity and regulatory uncertainty in the crypto space.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Lumia is the first next-generation blockchain offering a comprehensive solution for the entire life cycle of real-world assets (RWAs), from asset tokenization to liquidity aggregation and connectivity with millions of DeFi and Web3 traders.
Read more on LUMIA →